Department of Respiratory Diseases, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Curr Med Sci. 2019 Aug;39(4):560-567. doi: 10.1007/s11596-019-2074-7. Epub 2019 Jul 25.
Positive bronchodilation (BD) tests can be noticed in some stable chronic obstructive pulmonary disease (COPD) patients. The characteristics of airway inflammation in this entity remain unclear. Our study aimed to identify the characteristics of airway inflammation in stable COPD patients with positive BD tests. The airway inflammation was assessed in 88 patients with stable COPD using the examination of induced sputum in the aftermath of lung function and BD tests. Cellular counts and the levels of molecular markers including eosinophil cationic protein (ECP), myeloperoxidase (MPO), interleukin-5 (IL-5), and IL-8 were assayed by Wright's stain, Immuno-CAP system, and ELISA, RT-PCR. Among the 88 patients with stable COPD, 20 (22.7%) showed positive BD tests. The values of eosinophils (4.7%±3.4%) and ECP (90.1±41.6 ng/mL) in induced sputum in stable COPD patients with positive BD tests were markedly elevated as compared with those in stable COPD patients with negative BD tests or in healthy controls (all P>0.05), but significantly lower than those in asthmatic patients (all P<0.01). The IL-5 in sputum supernatant was significantly decreased in stable COPD patients with positive BD tests as compared with the patients with asthma (12.5±7.8 vs. 48.2±26.0 ng/mL;.P<0.01). However, healthy controls exhibited similar concentrations of IL-5 in induced sputum with patients with stable COPD, whether with positive or negative BD tests (all P>0.05). Moreover, the values of neutrophils (61.8%±15.1%), MPO (574.0±111.8 ng/mL), and IL-8 (32.6±13.4 ng/mL) in induced sputum in stable COPD patients with positive BD tests were significantly higher than those in asthmatics or normal controls (all P<0.01). However, the values of the above inflammatory markers in induced sputum were similar among stable COPD patients with positive or negative BD tests (all P>0.05). The stable COPD patients with positive BD tests may present not only eosinophilic airway inflammation but also neutrophilic airway inflammation.
部分稳定期慢性阻塞性肺疾病(COPD)患者可出现阳性支气管扩张试验(BD)。目前尚不清楚此类患者气道炎症的特点。本研究旨在明确稳定期 COPD 患者中阳性 BD 试验的气道炎症特点。通过肺功能及 BD 试验后诱导痰检查,对 88 例稳定期 COPD 患者的气道炎症进行评估。通过瑞氏染色、免疫 CAP 系统和 ELISA、RT-PCR 检测细胞计数和嗜酸性粒细胞阳离子蛋白(ECP)、髓过氧化物酶(MPO)、白细胞介素-5(IL-5)和白细胞介素-8(IL-8)等分子标志物的水平。在 88 例稳定期 COPD 患者中,20 例(22.7%)BD 试验阳性。与 BD 试验阴性或健康对照组相比,BD 试验阳性的稳定期 COPD 患者诱导痰中嗜酸性粒细胞(4.7%±3.4%)和 ECP(90.1±41.6 ng/mL)水平显著升高(均 P>0.05),但显著低于哮喘患者(均 P<0.01)。与哮喘患者相比,BD 试验阳性的稳定期 COPD 患者痰上清液中 IL-5 明显降低(12.5±7.8 vs. 48.2±26.0 ng/mL;P<0.01)。然而,健康对照组与稳定期 COPD 患者的诱导痰中 IL-5 浓度相似,无论是 BD 试验阳性还是阴性(均 P>0.05)。此外,BD 试验阳性的稳定期 COPD 患者诱导痰中中性粒细胞(61.8%±15.1%)、MPO(574.0±111.8 ng/mL)和 IL-8(32.6±13.4 ng/mL)水平明显高于哮喘患者或健康对照组(均 P<0.01)。然而,BD 试验阳性和阴性的稳定期 COPD 患者诱导痰中上述炎症标志物的水平相似(均 P>0.05)。BD 试验阳性的稳定期 COPD 患者可能同时存在嗜酸性粒细胞气道炎症和中性粒细胞气道炎症。